Notice of AGM

RNS Number : 6599G
Impact Healthcare REIT PLC
31 March 2022
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than the Republic of Ireland or the Netherlands), Canada, Australia, Japan or the Republic of South Africa.

 

 

31 March 2022

 

Impact Healthcare REIT plc

("Impact" or the "Company" or, together with its subsidiaries, the "Group")

2022 Notice of Annual General Meeting

The Board of Directors of Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust which gives investors exposure to a diversified portfolio of UK healthcare real estate assets, in particular care homes, is pleased to announce that the 2022 Notice of Annual General Meeting is now available to view on the Company's website at https://www.impactreit.uk/investors/reporting-centre/ .

 

The Company's Annual General Meeting will be held at 11.30 a.m. on Wednesday, 11 May 2022, at the offices of Travers Smith LLP, 10 Snow Hill, London EC1A 2AL.

 

The formal Notice of the Annual General Meeting will be posted to those shareholders who have requested that the Company should continue with postal correspondence and in accordance with Listing Rule 9.6.1 has been submitted to the Financial Conduct Authority and will shortly be available for inspection from the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

 

Following the removal of COVID-19 restrictions by the UK Government, this year's AGM will follow its usual format by being held in person as the Board considers it important that Shareholders continue to have opportunities to engage with it. Nonetheless, Shareholders are advised to follow the UK Government's advice on reducing the risk of spreading COVID-19.

 

The Board also encourages Shareholders to vote on any of the matters of business at the AGM in advance by proxy.

 

 

 

If circumstances change before the AGM, the Company will consider making appropriate changes and if it is appropriate notify shareholders of any changes to the proposed format for the AGM as soon as possible via RIS and its website ( https://www.impactreit.uk ).

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Impact Health Partners LLP

Mahesh Patel

Andrew Cowley

via Maitland/AMO



Winterflood Securities Limited

Joe Winkley

Neil Langford

Tel: 020 3100 0000



RBC Capital Markets

Rupert Walford

Matthew Coakes

Tel: 020 7653 4000



Maitland/AMO (Communications Adviser)

James Benjamin

Tel: 020 7379 5151

Email: impacthealth-maitland@maitland.co.uk



JTC (UK) Limited - Company Secretary

Christopher Gibbons

Tel: 0203 846 9774

Email: Impact.CoSec@jtcgroup.com

 

The Company's LEI is 213800AX3FHPMJL4IJ53.

 

Further information on Impact Healthcare REIT is available at www.impactreit.uk .

 

NOTES:

Impact Healthcare REIT plc acquires, renovates, extends and redevelops high quality healthcare real estate assets in the UK and lets these assets on long-term full repairing and insuring leases to high-quality established healthcare operators which offer good quality care, under leases which provide the Company with attractive levels of rent cover .

 

The Company aims to provide shareholders with an attractive sustainable return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified and resilient portfolio of UK healthcare real estate assets, in particular care homes for the elderly.

 

The Company has a progressive dividend policy with a target to grow its annual aggregate dividend in line with the inflation-linked rental uplifts received by the Group under the terms of the rent review provisions contained in the Group's leases in the prior financial year.

 

The Company's target total dividend for the year ending 31 December 2022 is 6.54 pence per share 1 , a 2.0% increase over the 6.41 pence in dividends paid or declared per ordinary share for the year ended 31 December 2021.

 

The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, premium segment, on 8 February 2019. The Company is a constituent of the FTSE EPRA/NAREIT index.

 

Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

1 This is a target only and not a profit forecast. There can be no assurance that the target will be met and it should not be taken as an indicator of the Company's expected or actual results.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAJMMLTMTJJBTT
UK 100